centigram – Talk Bio

Actionable Insights Powered by AI

Breakthroughs in Bladder Cancer Treatment: Protara and CG Oncology Report Encouraging Outcomes

5 months ago talkbio0Tagged Carcinoma of urinary bladder, invasive, Cell Therapy, centigram, Cretostimogene Grenadenorepvec, Lyophilized Inactivated Group A Streptococcus TARA-002, Malignant Neoplasms, Neoplasms, Non-Muscle, Non-Muscle Invasive Bladder Neoplasms, Oncolytic Immunotherapy, Protara Therapeutics, Urinary Bladder

Bladder Cancer Treatment, Protara Therapeutics, CG Oncology, TARA-002, Cretostimogene Grenadenorepvec, Non-Muscle Invasive Bladder Cancer (NMIBC), Oncolytic Immunotherapy, Cell Therapy

CG Oncology’s Immunotherapy Shows Promising Complete Response Rate in Bladder Cancer Patients

12 months ago talkbio0Tagged Cancer Therapeutic Procedure, centigram, Clinical Trials, Immunotherapy, Malignant neoplasm of urinary bladder, Neoplasms

CG Oncology, immunotherapy, bladder cancer, complete response rate, clinical trials, cancer treatment.